Background: Diabetic retinopathy (DR) is a major cause of blindness globally. Sodium Glucose Cotransporter-2 (SGLT2) inhibitors have been demonstrated to exert cardiorenal protection in patients with diabetes. However. their potential beneficial effect on DR is less well studied. https://www.bekindtopets.com/flash-sale-Grid-Dot-Polka-Dot-Xbox-Series-X-Controller-Skin-p60097-big-savings/